Tissue Engineering And Nanotheranostics

“9.61x6.69” b2815 Tissue Engineering and Nanotheranostics

Multifunctional Nanomaterials for Cancer Theranostics 275

243. Baselga J, Norton L, Albanell J, Kim YM, Mendelsohn J. Recombinant
     humanized anti­HER2 antibody (Herceptin) enhances the antitumor
     activity of paclitaxel and doxorubicin against HER2/neu overexpress­
     ing human breast cancer xenografts. Cancer Res. 58 , 2825–2831
     (1998).


244. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth
     J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe
     G, Rogers B, Ross R, Kabbinavar F. Bevacizumab plus irinotecan, fluo­
     rouracil, and leucovorin for metastatic colorectal cancer. N. Engl. J.
     Med. 350 , 2335–2342 (2004).


245. Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro
     A, Bets D, Mueser M, Harstrick A, Verslype C, Chau I, Van Cutsem E.
     Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan­
     refractory metastatic colorectal cancer. N. Engl. J. Med. 351 , 337–345
     (2004).


246. Cavanaugh PG, Jia L, Zou Y, Nicolson GL. Transferrin receptor over­
     expression enhances transferrin responsiveness and the metastatic
     growth of a rat mammary adenocarcinoma cell line. Breast Cancer Res.
     Treat. 56 , 203–217 (1999).


247. Pang Z, Gao H, Yu Y, Guo L, Chen J, Pan S, Ren J, Wen Z, Jiang X.
     Enhanced intracellular delivery and chemotherapy for glioma rats by
     transferrin­conjugated biodegradable polymersomes loaded with dox­
     orubicin. Bioconjugate Chem. 22 , 1171–1180 (2011).


248. Yuan Y, Chen S, Paunesku T, Gleber SC, Liu WC, Doty CB, Mak R,
     Deng J, Jin Q, Lai B, Brister K, Flachenecker C, Jacobsen C, Vogt S,
     Woloschak GE. Epidermal growth factor receptor targeted nuclear
     delivery and high­resolution whole cell X­ray imaging of Fe3O4@TiO2
     nanoparticles in cancer cells. ACS Nano. 7 , 10502–10517 (2013).


249. Mukherjee A, Darlington T, Baldwin R, Holz C, Olson S, Kulkarni P,
     DeWeese TL, Getzenberg RH, Ivkov R, Lupold SE. Development and
     screening of a series of antibody­conjugated and silica­coated iron
     oxide nanoparticles for targeting the prostate­specific membrane anti­
     gen. Chem. Med. Chem. 9 , 1356–1360 (2014).


250. Hong G, Yuan R, Liang B, Shen J, Yang X, Shuai X. Folate­
     functionalized polymeric micelle as hepatic carcinoma­targeted, MRI­
     ultrasensitive delivery system of antitumor drugs. Biomed. Microdevices
     10 , 693–700 (2008).


251. Kularatne SA, Low PS. Targeting of nanoparticles: Folate receptor.
     Methods Mol. Biol. 624 , 249–265 (2010).